A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease

Marcell Csanadi, Tamas Agh, A. Tordai, Thomas Webb, Dusha Jeyakumaran, Nishan Sengupta, Frida Schain, Jonas Mattsson

Research output: Contribution to journalReview article

Abstract

Introduction: Chronic graft-versus-host disease (chronic GVHD) is a leading cause of late death and contributes significantly to morbidity following hematopoietic stem cell transplantation. This study aims to provide a systematic literature review on incidence, mortality, and relapse of chronic GVHD patients. Areas covered: The authors searched for English-language articles published between 2007 and 2017 using PubMed. Studies that applied the 2005 or 2015 NIH Consensus Criteria for the diagnosis and staging of chronic GVHD, and had a cohort size of at least 100 patients were included. Expert opinion: The authors found a wide variation of incidence rates, which can be explained by heterogeneity in the characteristics of study samples and applied transplantation protocols. Chronic GVHD was associated with higher non-relapse mortality (NRM), superior overall survival (OS) and lower risk of relapse. Studies indicated an increased risk for NRM and worse OS in the presence of more severe disease. Future therapies should focus to reach a delicate balance between controlling disease severity among patients diagnosed with chronic GVHD and preserving the graft versus tumor effect which goes along with chronic GVHD and results in improved OS and decreased relapse rate. Nonetheless, factors predicting disease severity still need to be further understood.

Original languageEnglish
Pages (from-to)311-323
Number of pages13
JournalExpert Review of Hematology
Volume12
Issue number5
DOIs
Publication statusPublished - May 4 2019

Fingerprint

Graft vs Host Disease
Recurrence
Mortality
Incidence
Survival
Hematopoietic Stem Cell Transplantation
Expert Testimony
PubMed
Cause of Death
Consensus
Language
Transplantation
Morbidity
Transplants
Neoplasms

Keywords

  • Chronic graft-versus-host disease
  • clinical burden
  • cumulative incidence
  • non-relapse mortality
  • overall survival
  • relapse incidence
  • systematic literature review

ASJC Scopus subject areas

  • Hematology

Cite this

A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. / Csanadi, Marcell; Agh, Tamas; Tordai, A.; Webb, Thomas; Jeyakumaran, Dusha; Sengupta, Nishan; Schain, Frida; Mattsson, Jonas.

In: Expert Review of Hematology, Vol. 12, No. 5, 04.05.2019, p. 311-323.

Research output: Contribution to journalReview article

Csanadi, Marcell ; Agh, Tamas ; Tordai, A. ; Webb, Thomas ; Jeyakumaran, Dusha ; Sengupta, Nishan ; Schain, Frida ; Mattsson, Jonas. / A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. In: Expert Review of Hematology. 2019 ; Vol. 12, No. 5. pp. 311-323.
@article{a7ea5b5ada7b432caeb4677f83992488,
title = "A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease",
abstract = "Introduction: Chronic graft-versus-host disease (chronic GVHD) is a leading cause of late death and contributes significantly to morbidity following hematopoietic stem cell transplantation. This study aims to provide a systematic literature review on incidence, mortality, and relapse of chronic GVHD patients. Areas covered: The authors searched for English-language articles published between 2007 and 2017 using PubMed. Studies that applied the 2005 or 2015 NIH Consensus Criteria for the diagnosis and staging of chronic GVHD, and had a cohort size of at least 100 patients were included. Expert opinion: The authors found a wide variation of incidence rates, which can be explained by heterogeneity in the characteristics of study samples and applied transplantation protocols. Chronic GVHD was associated with higher non-relapse mortality (NRM), superior overall survival (OS) and lower risk of relapse. Studies indicated an increased risk for NRM and worse OS in the presence of more severe disease. Future therapies should focus to reach a delicate balance between controlling disease severity among patients diagnosed with chronic GVHD and preserving the graft versus tumor effect which goes along with chronic GVHD and results in improved OS and decreased relapse rate. Nonetheless, factors predicting disease severity still need to be further understood.",
keywords = "Chronic graft-versus-host disease, clinical burden, cumulative incidence, non-relapse mortality, overall survival, relapse incidence, systematic literature review",
author = "Marcell Csanadi and Tamas Agh and A. Tordai and Thomas Webb and Dusha Jeyakumaran and Nishan Sengupta and Frida Schain and Jonas Mattsson",
year = "2019",
month = "5",
day = "4",
doi = "10.1080/17474086.2019.1605288",
language = "English",
volume = "12",
pages = "311--323",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease

AU - Csanadi, Marcell

AU - Agh, Tamas

AU - Tordai, A.

AU - Webb, Thomas

AU - Jeyakumaran, Dusha

AU - Sengupta, Nishan

AU - Schain, Frida

AU - Mattsson, Jonas

PY - 2019/5/4

Y1 - 2019/5/4

N2 - Introduction: Chronic graft-versus-host disease (chronic GVHD) is a leading cause of late death and contributes significantly to morbidity following hematopoietic stem cell transplantation. This study aims to provide a systematic literature review on incidence, mortality, and relapse of chronic GVHD patients. Areas covered: The authors searched for English-language articles published between 2007 and 2017 using PubMed. Studies that applied the 2005 or 2015 NIH Consensus Criteria for the diagnosis and staging of chronic GVHD, and had a cohort size of at least 100 patients were included. Expert opinion: The authors found a wide variation of incidence rates, which can be explained by heterogeneity in the characteristics of study samples and applied transplantation protocols. Chronic GVHD was associated with higher non-relapse mortality (NRM), superior overall survival (OS) and lower risk of relapse. Studies indicated an increased risk for NRM and worse OS in the presence of more severe disease. Future therapies should focus to reach a delicate balance between controlling disease severity among patients diagnosed with chronic GVHD and preserving the graft versus tumor effect which goes along with chronic GVHD and results in improved OS and decreased relapse rate. Nonetheless, factors predicting disease severity still need to be further understood.

AB - Introduction: Chronic graft-versus-host disease (chronic GVHD) is a leading cause of late death and contributes significantly to morbidity following hematopoietic stem cell transplantation. This study aims to provide a systematic literature review on incidence, mortality, and relapse of chronic GVHD patients. Areas covered: The authors searched for English-language articles published between 2007 and 2017 using PubMed. Studies that applied the 2005 or 2015 NIH Consensus Criteria for the diagnosis and staging of chronic GVHD, and had a cohort size of at least 100 patients were included. Expert opinion: The authors found a wide variation of incidence rates, which can be explained by heterogeneity in the characteristics of study samples and applied transplantation protocols. Chronic GVHD was associated with higher non-relapse mortality (NRM), superior overall survival (OS) and lower risk of relapse. Studies indicated an increased risk for NRM and worse OS in the presence of more severe disease. Future therapies should focus to reach a delicate balance between controlling disease severity among patients diagnosed with chronic GVHD and preserving the graft versus tumor effect which goes along with chronic GVHD and results in improved OS and decreased relapse rate. Nonetheless, factors predicting disease severity still need to be further understood.

KW - Chronic graft-versus-host disease

KW - clinical burden

KW - cumulative incidence

KW - non-relapse mortality

KW - overall survival

KW - relapse incidence

KW - systematic literature review

UR - http://www.scopus.com/inward/record.url?scp=85065181164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065181164&partnerID=8YFLogxK

U2 - 10.1080/17474086.2019.1605288

DO - 10.1080/17474086.2019.1605288

M3 - Review article

VL - 12

SP - 311

EP - 323

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 5

ER -